leon-nanodrugs GmbH (“l(fā)eon”) is pleased to announce that its proprietary MicroJet Reactor (MJR?) nano-technology has been selected by Takeda Pharmaceutical Company Ltd. (Takeda) for a feasibility assessment that could potentially lead to the development o